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Abstract
Objectives: The aim was to determine which generations of the evolving technology of magnetic reso-
nance angiography (MRA) are currently of clinical relevance in two clinical applications. Our purpose
was to plan a systematic review that would be valuable both to purchasers driven by cost-effectiveness
and to practicing clinicians.
Methods: Information was gathered from a search of major bibliographic databases, from a short
questionnaire sent to 500 U.K. vascular radiologists and vascular surgeons, and from local clinical
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experts. We asked which of the MRA techniques were currently used and, assuming availability, what
would be their technique of choice.
Results: There were 206 published articles that satisfied preliminary inclusion criteria: 69 discussed
2D time of flight (TOF); 47, 3D TOF; and 38, contrast-enhanced techniques. There were 162 question-
naires returned (60 radiologists, 102 surgeons). Of the total respondents, 77/162 (48%) used MRA in
the assessment of carotid artery stenosis; 47/77 (61%) used 2D TOF; 32/77 (42%), 3D TOF; and 26/77
(34%), contrast-enhanced techniques. Thirty-five of 162 (22%) respondents used MRA in the assess-
ment of peripheral vascular disease (PVD); 15/35 (43%) used 2D TOF, 4/35 (11%) used 3D TOF, and
22/35 (63%) used contrast-enhanced techniques. For those wishing to use MRA, contrast-enhanced
techniques were the method of choice.
Conclusions: The TOF methods that represent earlier generations of the technology remain clinically
relevant, and will therefore be included in our systematic review. To ensure complete and relevant
coverage in reviews of other evolving technologies, it would be advisable to obtain data for guidance in
a similar way.
Keywords: Technology, Health care, Assessment, Technology, Angiography, Magnetic resonance, Re-
view literature, Online systems
The use of the systematic literature review as a tool to inform evidence-based therapeutics is
common. Its use in diagnostic practice, although equally necessary to ensure quality of care
and cost-effective use of resources, has yet to gain widespread acceptance. Although there
is extensive literature in the field of diagnostic imaging, systematic reviewing in this area
carries particular difficulties. The appropriate concepts and methods for rigorous evaluation
of a diagnostic technology are well understood (6;8;11;16;17). In practice, however, the
quality of the available literature is generally poor, with few large-scale studies and low
standards of study design and reporting (1;9;14). The literature may not necessarily reflect
practice in the country in which the review findings are to be applied. In addition, the
diagnostic technology is evolving rapidly, and uptake of new generations often precedes the
availability of evidence by some time (10;13). Uptake of new generations may also be guided
by the needs of diagnostic practitioners rather than by the requirements of medical or surgical
end-users. Under these circumstances, it is particularly important that any systematic review
undertaken addresses a tightly predefined clinical question and that all generations of the
technology that remain clinically relevant are considered.
Patients with atherosclerosis of the carotid or peripheral arteries may be investigated
by conventional catheter angiography and/or magnetic resonance angiography (MRA) or
ultrasound. Although conventional catheter x-ray angiography remains the definitive imag-
ing technique, it involves the use of ionizing radiation and is an invasive procedure carrying
a risk of stroke of up to 4%, when used in the carotid arteries of a symptomatic popula-
tion (5). These drawbacks have helped drive the introduction of duplex ultrasound and of
MRA, although MRA can lead to overestimation of the degree of stenosis caused by imag-
ing artifacts and low spatial resolution. MRA may also be of particular use in individuals
not normally suitable for conventional angiography, such as the frail and elderly (12) and
patients with renal insufficiency.
MRA is a rapidly evolving diagnostic imaging technology. The generations of the
technology include 2D time of flight (TOF), 3D TOF, and most recently, contrast-enhanced
techniques. Phase contrast techniques have been widely investigated in technical studies
but have not generally entered clinical practice. Use of the techniques has overlapped, and
none has completely replaced the others. Where MRA is applied to the surgical assessment
of carotid artery stenosis and peripheral vascular disease (PVD), it is important that both
the indications for, and the clinical utility of, all generations in current use be established
as rapidly as possible. The aim is to avoid expenditure on units that are not needed and to
ensure the most appropriate use. The primary research question to be addressed by the full
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systematic review (3) was set in the U.K. National Health Service (NHS) Health Technology
Assessment (HTA) commissioning brief: What is the cost-effectiveness of MRA compared
with conventional angiography in carotid artery stenosis and peripheral vascular disease?
The results of the review are intended to be used within the U.K. NHS, so the work has a
U.K. focus.
The purpose of this preliminary study was to determine which of the various generations
of the technology are currently of clinical relevance, in order to establish the scope of the
full systematic review into the cost-effectiveness of MRA.
METHODS
Two approaches, determined in advance by review team discussion, were taken. First, to
determine which MRA techniques have been evaluated in the literature, a preliminary
literature search was performed. Second, to define the appropriate clinical questions and
to determine which generations of MRA technology remain clinically relevant, advice was
sought from practitioners other than those on the review team by national survey.
Preliminary information on the available published evidence was gathered using the
major electronic bibliographic databases: MEDLINE, EMBASE, HealthSTAR, Science
Citation Index (SCI), and Index of Scientific and Technical Proceedings (ISTP). A broad
search strategy for MRA and related terms was used to maximize sensitivity (2). Before
the number of articles published describing the various generations of the technology was
determined, the first of several sets of exclusion criteria to be applied in the full systematic
review (3) was used. Duplicated references were excluded, then criteria designed to exclude
articles that did not present relevant original research were applied. The criteria were first
applied within the databases, where possible, using the database indexing to electronically
exclude review articles, editorials, letters, case reports, conference abstracts, and articles
using nonhuman subjects. In the second application, a reviewer manually repeated these
criteria for the remaining references, and excluded articles that did not involve the target
technology in the correct clinical application, articles on technical developments, those
involving pediatric subjects, and those with 10 or fewer subjects. A breakdown of the
number of exclusions for each bibliographic database was made to help inform the execution
of future systematic reviews.
To define the appropriate clinical questions and to determine which generations of
MRA technology remain clinically relevant, advice was sought using a structured approach
predetermined by the review team, which included experts in radiology, vascular surgery,
and Neurology. A questionnaire was sent to 100 radiologists and 400 vascular surgeons in
the United Kingdom, and the survey results were processed by nonclinical members of the
review team. In order to determine the continuing clinical relevance of each generation of the
technology, the questionnaire sought information on MRA techniques currently available
to each group. Recipients were also asked to state their technique of choice, if all methods
were equally available, for each clinical application (carotid artery stenosis and PVD). This
was to provide an indication of both the level and source of demand; is the rapid evolution
of MRA primarily led by the needs of clinical end-users or by diagnostic practitioners? To
encourage responses, the questionnaire comprised only six questions and was in the form
of a single-page letter suitable for return by fax.
RESULTS
The initial literature search of the bibliographic databases identified 16,185 articles. How-
ever, there was a high rate of duplication between databases (Table 1), leaving a total of
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7,183 unique articles. Many articles were not original research relevant to MRA and to
carotid artery stenosis or PVD (Table 2), and a total of 206 potentially useful articles was
left, just 1% of the original retrieval. Many of the articles were concerned with more than
one MRA technique. It could be seen from the abstracts that 69 were concerned with the use
of 2D TOF, 47 with 3D TOF, and 38 with contrast-enhanced techniques. Twenty discussed
phase-contrast MRA, and the focus of a further 73 was not clear from the abstract. Only
nine of the 206 articles were from the United Kingdom, while there were 93 from the United
States, and 75 from countries in western Europe other than the United Kingdom.
The review team experts in radiology, vascular surgery, and neurology favored contrast-
enhanced techniques, although in one hospital only contrast-enhanced techniques are em-
ployed. TOF techniques are commonly used in the other hospitals to which they are affiliated.
There were 162 (32%) questionnaires returned from 60 radiologists out of a total of 100
surveyed and 102 vascular surgeons out of a total of 400 surveyed. Of 142 respondents, 162
(88%) respondents had MRA available on site (Figure 1), with 108 of 162 (67%) having
access to 2D TOF, 96 of 162 (60%) to 3D TOF, and 85 of 162 (52%) to contrast-enhanced
techniques. Seventy-seven of 162 (48%) respondents gave details of the MRA methods they
currently used in the assessment of carotid artery stenosis (Figure 2A), with 47 of 77 (61%)
using 2D TOF, 32 of 77 (42%) using 3D TOF, and 26 of 77 (34%) using contrast-enhanced
techniques. Thirty-five of 162 (22%) respondents gave details of the MRA methods they
currently used in the assessment of PVD (Figure 2B), with 15 of 35 (43%) using 2D TOF,
4 of 35 (11%) using 3D TOF, and 22 of 35 (63%) using contrast-enhanced techniques. Fifty-
one of 60 (85%) responding radiologists expressed a preference, and 49 of 51 (96%) would
use MRA for the evaluation of carotid artery stenosis (Figure 3A); 32 of 49 (65%) would
choose contrast-enhanced techniques. For the evaluation of PVD, 45 of 60 (75%) responding
Table 1. Number of Unique Articles Retrieved from Each Database
MEDLINE EMBASE HealthSTAR SCI ISTP Total
Initial number of articles retrieved 4,649 4,040 3,523 3,732 241 16,185
Number remaining after 4,649 1,208 147 1,055 124 7,183
exclusion of duplicates
(Percentage shown in parenthesis) (100%) (30%) (4%) (28%) (51%) (44%)
The last column shows the sum from all five databases. The databases were assessed for duplication in a hierarchical
manner, moving from left to right of the table.
Table 2. Number of Articles Excluded from Each Database Using the Exclusion Criteria
Exclusion criterion MEDLINE EMBASE HealthSTAR SCI ISTP Total
Review 951 240 45 66 2 1,304
Editorial 42 35 0 46 0 123
Letter 46 37 1 27 0 114
Case report 1,130 383 23 16 0 1,552
Conference abstract 1 1 1 473 11 487
Nonhuman subjects 260 102 2 2 6 407
Not applicable (see text) 1,823 389 66 336 80 2,694
Technical development 78 16 5 37 23 159
Pediatric subjects 12 1 0 1 0 14
Ten or fewer subjects 105 9 1 8 0 123
Number of articles 4,474 1,190 144 1,047 122 6,977
excluded
Number remaining after 175 18 3 8 2 206
exclusions
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Figure 1. Response to questionnaire: Availability of MRA techniques on site (nD 162).
radiologists expressed a preference, and 39 of 45 (87%) would use MRA (Figure 3B); 36 of
39 (92%) of these would choose contrast-enhanced techniques. For the evaluation of carotid
artery stenosis, 77 of 102 (75%) responding surgeons expressed a preference, and 37 of
77 (49%) would use MRA (Figure 4A); 28 of 37 (76%) would choose contrast-enhanced
techniques. For the evaluation of PVD, 75 of 102 (74%) responding surgeons expressed
a preference, and 41 of 75 (55%) would use MRA (Figure 4B); 40 of 41 (98%) of these
would choose contrast-enhanced techniques.
DISCUSSION
Although there was considerable overlap between the bibliographic databases searched,
all the databases returned some articles unique to that database, and there were articles
remaining from all the databases after the exclusion criteria had been applied. Our purpose
here was to determine the approximate proportion of published articles for each generation
of the technology. The results suggest that a search restricted to MEDLINE, EMBASE, and
the Science Citation Index would have been adequate. A description of the full systematic
review, including the final inclusion criteria and consideration of quality issues, is given
elsewhere (3). In spite of the large pool of candidate articles, only 35 articles concerning
assessment of the carotid arteries and 20 articles on assessment of the peripheral circulation
were included in the systematic review and quantitative meta-analysis.
The existing literature on the diagnostic performance of MRA broadly reflected current
usage patterns, although there remains a dearth of evidence to support the expanding use of
contrast-enhanced techniques. It would be unwise to rely solely upon preliminary literature
searches to determine the scope of a systematic review in a rapidly evolving field because
of the time lag between uptake of the latest generation and publication of studies evaluating
it. There are also potential differences in usage and publication patterns between different
countries.
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Figure 2. Current use of MRA techniques in the assessment of (A) carotid artery stenosis
and (B) peripheral vascular disease (nD 162).
In general, TOF techniques remain in widespread use, and there is a significant body
of published work evaluating their diagnostic performance. Where users—in particular,
radiologists—expressed a preference, they tended to favor the most recent technology,
even though the published evidence evaluating its diagnostic performance may be limited.
Clinical end-users, in this case vascular surgeons, were more cautious in their use of MRA,
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Figure 3. Techniques preferred by radiologists for the assessment of (A) carotid artery
stenosis and (B) peripheral vascular disease (nD 60).
often preferring not to use it at all. They were more likely to be satisfied with the technique
that is currently available to them. However, these observations were not obtained using
a rigorous methodology such as conjoint analysis, which is increasingly being applied to
study both patient (4;15) and clinician (7) preferences.
Although decisions on new purchases should be driven by data on the generation of
technology that is to be acquired, information about other generations in current use is of
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Figure 4. Techniques preferred by vascular surgeons for the assessment of (A) carotid
artery stenosis and (B) peripheral vascular disease (nD 102).
value in measuring incremental cost-effectiveness and informing clinical practice. In the
case of MRA, we found from this survey that time-of-flight techniques remain clinically
relevant to the assessment of both carotid artery stenosis and PVD, so they were included
in our systematic review.
To ensure complete and relevant coverage in reviews of other evolving technologies, it
would advisable to gather data from the target population of users in a similar way to that
illustrated here.
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